Gregory S. Curhan - 15 Aug 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Chief Financial Officer
Signature
/s/ Gregory S. Curhan
Issuer symbol
SER
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
4
Filing time
20 Aug 2024, 21:01:14 UTC
Previous filing
04 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 15 Aug 2024 Common Stock 250,000 $6.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in substantially equal monthly installments beginning on September 15, 2024 such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.